Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Kater AP"'
Autor:
Fürstenau M; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Cologne, Germany; German CLL Study Group, University of Cologne, Cologne, Germany. Electronic address: moritz.fuerstenau@uk-koeln.de., Kater AP; Department of Hematology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands., Robrecht S; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Cologne, Germany; German CLL Study Group, University of Cologne, Cologne, Germany., von Tresckow J; Clinic for Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany., Zhang C; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Cologne, Germany; German CLL Study Group, University of Cologne, Cologne, Germany., Gregor M; Division of Hematology, Cantonal Hospital of Lucerne, Lucerne, Switzerland., Thornton P; Department of Haematology, Beaumont Hospital, Dublin, Ireland., Staber PB; Department of Medicine I, Medical University of Vienna, Vienna, Austria., Tadmor T; Hematology, Bnai-Zion Medical Center, Haifa, Israel., Lindström V; Comprehensive Cancer Center, Department of Hematology, Helsinki University Hospital and University of Helsinki, Finland., Juliusson G; Department of Hematology, Skåne University Hospital, Lund, Sweden., Janssens A; Universitaire Ziekenhuizen Leuven, Leuven, Belgium., Levin MD; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, Netherlands., da Cunha-Bang C; Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Schneider C; Division of CLL, Department of Internal Medicine III, University of Ulm, Ulm, Germany., Goldschmidt N; Department of Hematology, Hadassah Medical Center, Jerusalem, Israel., Vandenberghe E; St James Hospital, Dublin, Ireland., Rossi D; Division of Hematology, Oncology Institute of Southern Switzerland and Institute of Oncology Research, EOC and USI, Bellinzona, Switzerland., Benz R; Division of Hematology and Oncology, Cantonal Hospital, Münsterlingen, Switzerland., Nösslinger T; Medical University of Vienna, and the Department of Hematology and Oncology, Hanusch Hospital, Vienna, Austria., Heintel D; Division of Medicine I, Klinik Ottakring, Vienna, Austria., Poulsen CB; Department of Hematology, Zealand University Hospital, Roskilde, Denmark., Christiansen I; Department of Hematology, Aalborg University Hospital, Aalborg, Denmark., Frederiksen H; Department of Hematology, Odense University Hospital, Odense, Denmark., Enggaard L; Department of Hematology, Herlev Hospital, Herlev, Denmark., Posthuma EFM; Department of Internal Medicine, Reinier The Graaf Hospital, Delft, Netherlands., Issa DE; Jeroen Bosch hospital, Den Bosch, Netherlands., Visser HPJ; Department of Internal Medicine, Noordwest ziekenhuisgroep, Alkmaar, Netherlands., Bellido M; Department of Hematology, Groningen University Medical Center, University of Groningen, Groningen, Netherlands., Kutsch N; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Cologne, Germany; German CLL Study Group, University of Cologne, Cologne, Germany., Dürig J; Department of Internal Medicine, St Josef Krankenhaus Werden, University Medicine Essen, Essen, Germany., Stehle A; Department of Hematology and Oncology, Robert-Bosch-Krankenhaus, Stuttgart, Germany., Vöhringer M; Department of Hematology and Oncology, Robert-Bosch-Krankenhaus, Stuttgart, Germany., Böttcher S; Department of Medicine III Hematology, Oncology and Palliative Care, University Hospital Rostock, Rostock, Germany., Schulte C; Gemeinschaftspraxis für Hämatologie und Onkologie, Dortmund, Germany., Simon F; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Cologne, Germany; German CLL Study Group, University of Cologne, Cologne, Germany., Fink AM; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Cologne, Germany; German CLL Study Group, University of Cologne, Cologne, Germany., Fischer K; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Cologne, Germany; German CLL Study Group, University of Cologne, Cologne, Germany., Holmes EE; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Cologne, Germany; German CLL Study Group, University of Cologne, Cologne, Germany., Kreuzer KA; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Cologne, Germany; German CLL Study Group, University of Cologne, Cologne, Germany., Ritgen M; Department II of Internal Medicine, University of Schleswig-Holstein, Kiel, Germany., Brüggemann M; Department II of Internal Medicine, University of Schleswig-Holstein, Kiel, Germany., Tausch E; Division of CLL, Department of Internal Medicine III, University of Ulm, Ulm, Germany., Stilgenbauer S; Division of CLL, Department of Internal Medicine III, University of Ulm, Ulm, Germany., Hallek M; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Cologne, Germany; German CLL Study Group, University of Cologne, Cologne, Germany., Niemann CU; Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Eichhorst B; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Cologne, Germany; German CLL Study Group, University of Cologne, Cologne, Germany.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2024 Jun; Vol. 25 (6), pp. 744-759.
Autor:
Kater AP; Department of Hematology, Cancer Center Amsterdam, Lymphoma and Myeloma Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Arslan Ö; Department of Hematology, Faculty of Medicine, Ankara University, Ankara, Turkey., Demirkan F; Department of Hematology, Faculty of Medicine, Dokuz Eylül University, Izmir, Turkey., Herishanu Y; Department of Hematology, Tel-Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel., Ferhanoglu B; Department of Hematology, Koç University Medical Faculty, Istanbul, Turkey., Diaz MG; Department of Hematology, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC), Salamanca, Spain., Leber B; Division of Hematology and Thromboembolism, Department of Medicine, McMaster University, Hamilton, ON, Canada., Montillo M; Department of Haematology, Niguarda Cancer Center, Niguarda Hospital, Milan, Italy., Panayiotidis P; First Department of Propedeutic Internal Medicine, National and Kapodistrian University of Athens, Laikon University Hospital, Athens, Greece., Rossi D; Institute of Oncology Research, Università della Svizzera Italiana, Bellinzona, Switzerland; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland., Skarbnik A; Lymphoproliferative Disorders Program, Novant Health Cancer Institute, Charlotte, NC, USA; John Theurer Cancer Center, Hackensack, NJ, USA., Tempescul A; Department of Clinical Hematology, University Teaching Hospital Brest, Brest, France., Turgut M; Department of Hematology, Ondokuz Mayıs University Faculty of Medicine, Samsun, Turkey., Mellink CH; Department of Human Genetics, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., van der Kevie-Kersemaekers AF; Department of Genetics, UMC Utrecht, Utrecht, The Netherlands., Lanham S; Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK., Sale B; Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK., Del Rio L; Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK., Popovic R; AbbVie, North Chicago, IL, USA., Chyla BJ; AbbVie, North Chicago, IL, USA., Busman T; AbbVie, North Chicago, IL, USA., Komlosi V; AbbVie, North Chicago, IL, USA., Wang X; AbbVie, North Chicago, IL, USA., Sail K; AbbVie, North Chicago, IL, USA., Pena GE; AbbVie, North Chicago, IL, USA., Vizkelety T; AbbVie, North Chicago, IL, USA., Forconi F; Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK; Haematology Department, Cancer Care Directorate, University Hospital Southampton NHS Trust, Southampton, UK. Electronic address: f.forconi@soton.ac.uk.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2024 Apr; Vol. 25 (4), pp. 463-473. Date of Electronic Publication: 2024 Mar 08.
Autor:
Niemann CU; Department of Hematology, Rigshospitalet, Copenhagen University Hospital, DK-2100 Copenhagen, Denmark. Electronic address: carsten.utoft.niemann@regionh.dk., Kater AP; Amsterdam University Medical Centers, Cancer Center Amsterdam, University of Amsterdam, Amsterdam, Netherlands.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2024 Feb; Vol. 25 (2), pp. e56.
Autor:
Niemann CU; Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. Electronic address: carsten.utoft.niemann@regionh.dk., Munir T; St James's Hospital, Leeds, UK., Moreno C; Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona, Josep Carreras Leukaemia Research Institute, Barcelona, Spain., Owen C; Tom Baker Cancer Centre, Calgary, AB, Canada., Follows GA; Addenbrookes Hospital, Cambridge, UK., Benjamini O; Sheba Medical Center, Ramat Gan, Israel., Janssens A; UZ Leuven Gasthuisberg, Leuven, Belgium., Levin MD; Albert Schweitzer Hospital, Dordrecht, Netherlands., Robak T; Medical University of Lodz, Copernicus Memorial Hospital, Lodz, Poland., Simkovic M; 4th Department of Internal Medicine-Haematology, Faculty of Medicine in Hradec Králové, University Hospital and Charles University in Prague, Hradec Králové, Czech Republic., Voloshin S; Russian Scientific and Research Institute of Hematology and Transfusiology, St Petersburg, Russia., Vorobyev V; SP Botkin Moscow City Clinical Hospital, Moscow, Russia., Yagci M; Gazi Universitesi Tip Fakultesi, Ankara, Türkiye., Ysebaert L; Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France., Qi K; Janssen Research & Development, Titusville, NJ, USA., Qi Q; Janssen Research & Development, Raritan, NJ, USA., Sinet P; Janssen Research & Development, Bridgewater, NJ, USA., Parisi L; Janssen Research & Development, Raritan, NJ, USA., Srinivasan S; Oncology Translational Research, Janssen Research & Development, Lower Gwynedd Township, PA, USA., Schuier N; Janssen Research & Development, Raritan, NJ, USA., Baeten K; Janssen Research & Development, Beerse, Belgium., Howes A; Janssen Research & Development, High Wycombe, UK., Caces DB; Janssen Research & Development, Raritan, NJ, USA., Kater AP; Amsterdam University Medical Centers, Cancer Center Amsterdam, University of Amsterdam, Amsterdam, Netherlands.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2023 Dec; Vol. 24 (12), pp. 1423-1433. Date of Electronic Publication: 2023 Nov 06.
Autor:
Kater AP; Department of Hematology, Cancer Center Amsterdam, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, Netherlands. Electronic address: a.p.kater@amsterdamumc.nl., Levin MD; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, Netherlands., Dubois J; Department of Hematology, Cancer Center Amsterdam, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, Netherlands., Kersting S; Department of Hematology, Haga Hospital, Den Haag, Netherlands., Enggaard L; Department of Hematology, Herlev Hospital, Copenhagen, Denmark., Veldhuis GJ; Department of Hematology, St Antonius Hospital, Sneek, Netherlands., Mous R; Department of Hematology, University Medical Center Utrecht, Utrecht, Netherlands., Mellink CHM; Department of Human Genetics, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, Netherlands., van der Kevie-Kersemaekers AF; Department of Human Genetics, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, Netherlands., Dobber JA; Laboratory of Special Hematology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, Netherlands., Poulsen CB; Department of Hematology, Zealand University Hospital, Roskilde, Denmark., Frederiksen H; Department of Hematology, Odense University Hospital, Odense, Denmark., Janssens A; Department of Hematology, UZ Leuven, Leuven, Belgium., Schjødt I; Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Dompeling EC; Department of Hematology, Isala Ziekenhuis, Zwolle, Netherlands., Ranti J; Department of Hematology, Turku University Central Hospital, Turku, Finland., Brieghel C; Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Mattsson M; Department of Hematology, Uppsala University Hospital, Uppsala, Sweden., Bellido M; Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands., Tran HTT; Department of Hematology, Akershus University Hospital, Lørenskog, Norway., Nasserinejad K; HOVON Data Center, Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands., Niemann CU; Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. Electronic address: carsten.utoft.niemann@regionh.dk.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2022 Jun; Vol. 23 (6), pp. 818-828.
Autor:
Kater AP; Department of Hematology and Lymphoma and Myeloma Center, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam 1105AZ, Netherlands. Electronic address: a.p.kater@amc.nl., Brown JR; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2019 Jan; Vol. 20 (1), pp. 3-5. Date of Electronic Publication: 2018 Dec 03.